1. Home
  2. Calendar of Events
  3. Events
  4. CAP Pathology in the Islands

CAP Pathology in the Islands

Pathology in the Islands

Dive in and Relax

Jun 26, 2023 - Jun 29, 2023
Atlantis Paradise Island, Paradise Island, Bahamas

Juggling priorities—especially when balancing your career and your family—can be difficult. To help you succeed, the CAP’s Pathology in the Islands program provides a unique educational experience combining a focused CME curriculum with built-in leisure time, helping you maintain a positive work-life balance. Internationally-known faculty will provide insights on topics you encounter every day in pathology practice, supporting your efforts to improve patient care and practice efficiency.

Pathology in the Islands – June 26–29, 2023

Pathology in the Islands is a CME event that balances pathologists’ personal and professional lives by combining concentrated learning sessions and downtime for leisure activities—and the tropical locale of Atlantis Paradise Island Resort is the perfect setting. The interactive program, led by internationally-known faculty, will grow your diagnostic skills in and your knowledge of the latest advances in pathology.

In 2023, our program will focus on Breast, Genitourinary, and Gynecologic Pathology. Education sessions will take place during the mornings, leaving afternoons free for you to explore the resort and its nearby attractions with your family or fellow participants.

Features of Pathology in the Islands include:

  • Four half-days of learning, with an afternoon start on Monday to accommodate late check-ins.
  • Morning education sessions Tuesday through Thursday, with afternoons open for downtime.
  • 45 to 50-minute presentations, with time built in for interaction and Q&A.
  • Ample opportunity to network with faculty and other participants in a relaxed environment.
  • 16 CME credits.

Note: Both US and Bahamas Immigration Laws require all travelers to have a valid passport.

Objectives

As an outcome of this conference, participants will be able to: 

  1. Identify, assess and diagnose neoplastic and non-neoplastic entities and their mimickers in breast, genitourinary, and gynecologic pathology.
  2. Be aware of diagnostic pitfalls that the expert faculty and peers have encountered in everyday practice.
  3. Manage common diagnostic challenges.
  4. Apply recent evidence-based guidelines and developments in ancillary testing to day-to-day work.
  5. Demonstrate their own knowledge and comprehension via activities and audience participation.

Program Schedule

1-1:15 PMWelcome
1:15-2:15 PMLobular neoplasia in situ 
Faculty: Edi Brogi, MD PhD
2:15-3:15 PMProblematic Proliferations: Recurrent Diagnostic Challenges
Faculty: Gary Tozbikian, MD
3:15-3:45 PMBreak
3:45-4:45 PMProstate Cancer Grading: Update 2021
Faculty: Michelle S. Hirsch, MD, PhD
4:45-5:45 PMBiopsy Diagnosis of Prostatic Adenocarcinoma
Faculty: Donna E. Hansel, MD, PhD
6-8 PMSocial Event
6:30-7:30 AMContinental Breakfast
7:30-8:30 AMPitfalls in the Diagnosis of High-grade Ovarian Carcinoma
Faculty: Esther Oliva, MD
8:30-9:30 AMThe Spectrum of High-grade Endometrial Carcinomas from Morphology to Molecular
Faculty: Esther Oliva, MD
9:30-10 AMBreak
10-11 AMPapillary Perplexities in Breast Pathology
Faculty: Gary Tozbikian, MD
11 AM -12 PMFibroepithelial lesions 
Faculty: Edi Brogi, MD PhD
6:30-7:30 AMContinental Breakfast
7:30-8:30 AMUpdates in Renal Neoplasia
Faculty: Donna E. Hansel, MD, PhD
8:30-9:30 AMChallenges in the Diagnosis of Non-invasive Bladder Lesions
Faculty: Michelle S. Hirsch, MD, PhD
9:30-10 AMBreak
10-11 AMMolar Disease and Mole Mimics
Faculty: Sarah Chiang, MD
11 AM-12 PMUterine Sarcoma Diagnosis: A Practical Approach
Faculty: Sarah Chiang, MD
6:30-7:30 AMContinental Breakfast
7:30-8:30 AMSpindle cell nightmares
Faculty: Edi Brogi, MD PhD
8:30-9:30 AMPredictive and Prognostic Biomarker Testing in Breast Cancer
Faculty: Gary Tozbikian, MD
9:30-10 AMBreak
10-11 AMInvasive Endocervical Adenocarcinoma: Selected Issues in Classification, Staging, and Differential Diagnosis
Faculty: Esther Oliva, MD
11 AM - 12 PMPractical Approach to the Classification and Staging of Invasive Urothelial Carcinoma
Faculty: Donna E. Hansel, MD, PhD
12- 12:15 PMClose

Meet the Faculty

  • Open all Toggle
  • Close all Toggle

Edi Brogi, M.D. Ph.D. is an Attending Pathologist and the Director of Breast Pathology at Memorial Sloan-Kettering Cancer Center. Dr. Brogi is a graduate of the University of Florence Medical School, in Florence, Italy. She trained in Anatomic Pathology at the Massachusetts General Hospital in Boston, followed by two additional years as Chief Resident/ Graduate Assistant with sign-out privileges and Cytopathology fellow at the same institution. In July 2000, Dr. Brogi joined the staff at Memorial Sloan Kettering Cancer Center in New York City, NY and has been practicing there since.

Dr. Brogi’s professional and research activities focus exclusively on the diagnosis, treatment, and study of breast diseases, particularly breast carcinoma. She is recognized as an expert in the field nationally and internationally. Dr. Brogi was a member of the USCAP Education Committee in 2012-2016. She was an Officer of the International Society of Breast Pathology 2012-2016, and President of the Society in 2017-2019. She currently serves on the editorial board of two journals.

Dr. Brogi has published nearly 200 original articles, review articles, and book chapters, predominantly focused on breast diseases. She is an expert member of the Editorial Board of the World Health Organization Blue Book on the Classification of Breast Tumors (5th Edition). She is also Associate Editor of Rosen’s Breast Pathology textbook (4th edition, 2014), and Rosen’s Breast Pathology by needle core biopsy textbook (4th edition, 2017).

Sarah Chiang, MD is an Assistant Attending Pathologist at Memorial Sloan Kettering Cancer Center, where she has been faculty member since 2013. She received her MD from the University of Arizona College of Medicine. She completed her residency in anatomic pathology and the Robert E. Scully fellowship in Gynecologic, Obstetric, and Urologic Pathology at the Massachusetts General Hospital. Thereafter, she joined Memorial Sloan Kettering and practices gynecologic pathology. Her research is focused on the genetic understanding of women’s cancers, particularly uterine sarcomas for which she has recently described several novel tumor entities. She serves on the editorial board of Modern Pathology and is a contributor to several chapters for the World Health Organization Classification of Tumours of Female Reproductive Organs, 5th edition. She has published numerous scientific articles, review articles, and book chapters on gynecologic pathology. She is actively involved in the education of pathologists and clinicians, giving numerous lectures and postgraduate CME courses at both national and international meetings. She is a member of several professional organizations, including the International Society of Gynecological Pathologists, International Gynecologic Cancer Society, and United States and Canadian Academy of Pathologists.

Dr. Donna Hansel completed a Bachelor of Science degree program in Biology at the Johns Hopkins University, graduating Phi Beta Kappa. She subsequently completed the M.D., Ph.D. Medical Scientist Training Program, pathology residency and urologic pathology fellowship at the Johns Hopkins School of Medicine. Dr. Hansel joined the Cleveland Clinic Anatomic Pathology Staff as Assistant Professor in 2006 as a subspecialty genitourinary pathologist and was promoted to Associate Professor in 2010. Dr. Hansel was subsequently recruited to the University of California at San Diego as a Professor of Pathology and Chief of the Division of Anatomic Pathology. In 2019, she assumed the role of Chair of Pathology at Oregon Health & Science University in Portland, Oregon.

Dr. Hansel has authored over 140 peer-reviewed publications, edited or authored 5 textbooks on urologic pathology and biospecimen repositories, and has participated in more than 60 national or international talks on bladder cancer. She has participated in the Kidney-Urinary tract panel for the 8th Edition of the AJCC Cancer Staging Manual and contributed to the upcoming 4th edition of the WHO Classification of Tumours of the Urinary System and Male Genital Organs. She is the Deputy Executive Editor for Archives of Pathology & Laboratory Medicine and is on the editorial board of American Journal of Surgical Pathology, Advances in Anatomic Pathology, American Journal of Pathology, and Histopathology. She has mentored over 30 residents, graduate students and postdoctoral fellows, while remaining active in clinical sign out. She is a member of Alpha Omega Alpha and has recently received the Ramzi S. Cotran Young Investigator Award from USCAP. She oversees an interdisciplinary laboratory research program in bladder cancer that incorporates advanced –OMICs technologies in the analysis of human bladder cancers and cell signaling pathway analysis to identify new targets for bladder cancer therapeutics development.

Michelle S. Hirsch, MD, PhD, is an Associate Professor of Pathology at Harvard Medical School in Boston, Massachusetts. Dr. Hirsch is board certified in Anatomic Pathology, is a practicing Surgical Pathologist at Brigham and Women's Hospital (BWH) and has been the Chief of the Genitourinary Pathology Division at BWH since 2010. Dr. Hirsch received both her M.D. and her Ph.D. (in Anatomy and Cell Biology) from Boston University School of Medicine. She completed her residency and fellowship training in genitourinary and gynecologic pathology at BWH prior to joining the staff at BWH in 2004. Her daily clinical and educational responsibilities are centered around genitourinary and gynecologic pathology, and she places a large emphasis on diagnostic pearls and clinico-pathologic correlation. Her primary research interests include diagnostic biomarker and genetic evaluation in subtyping renal and ovarian tumors. Dr. Hirsch has published ~150 peer reviewed articles, reviews and chapters, and previously edited the Genitourinary Pathology edition of Surgical Pathology Clinics. She is a prior member of the USCAP Education Committee, prior President of the New England Society of Pathologists, and is on the Editorial Board for Histopathology and Kidney Cancer. Dr. Hirsch has mentored over 40 residents, fellows and junior faculty members. She is a member of Alpha Omega Alpha, has received multiple teaching awards, and is passionate about sharing her knowledge of genitourinary and gynecologic pathology by lecturing domestically and internationally.

Dr. Esther Oliva is a member of the pathology department and codirector of the Gynecologic service at the Massachusetts General Hospital and Professor at Harvard University. Dr. Oliva was born in Barcelona, Catalonia (Spain) and trained under three of the most world-renowned gynecologic pathologists, Dr. Robert E Scully, Dr. Robert H. Young and Dr. Jaime Prat. She trained in anatomic pathology at the Hospital de la Santa Creu i Sant Pau (Barcelona) and the Massachusetts General Hospital. Her passion is to teach newer generations of pathologists from all over the world. Her research is mainly focused on neoplastic diseases involving the female genital tract (with a particular interest in mesenchymal tumors at morphologic, translational, and molecular levels) and the genitourinary tract. She is the past president of the International Society of Gynecological Pathology and past member of the standing committee for the fifth series of the World Health organization (WHO). She serves on the editorial board of the American Journal of Surgical Pathology, Modern Pathology, International Journal of Gynecologic Pathology, Advances in Anatomic Pathology, and Seminar in Diagnostic Pathology. She is a very active member of the USCAP. She has been a member of the abstract review board, educational committee and council. She was the co-director of the Long Course on Practical Topics in Uterine Pathology, and she has taught 5 short courses. She is the editor of the most recent AFIP fascicle on the Uterine Corpus and the co-editor of some of the most widely used textbooks in gynecologic pathology including "Gynecologic Pathology", first series (a volume part of “Foundations in Diagnostic Pathology) and "Diagnostic Pathology Gynecologic" (Amirsys) with Dr. Nucci, and editor of the monograph "Current Concepts in Gynecologic Pathology: Mesenchymal Tumors of the Female Genital Tract" (part of Surgical Pathology Clinics).

Dr. Tozbikian is an Anatomic and Clinical Pathology board-certified Surgical Pathologist with a specialization in Breast Pathology. His research is focused on diagnostic, predictive, and therapeutic biomarkers for use in breast cancer, as well as the practical application of advanced digital imaging technology in breast pathology. After earning his MD degree from The Ohio State University, he completed his Pathology Residency and General Surgical Pathology Fellowship at the Hospital of the University of Pennsylvania, and Breast Pathology Fellowship at Memorial Sloan Kettering Cancer Center. Dr. Tozbikian joined the Department of Pathology at The Ohio State University Wexner Medical Center in 2013. He is an Associate Professor and Breast Pathology Division Director, and serves as a subspecialty pathologist on the Breast and Genitourinary Pathology services.

Registration

This program is for CAP members only. The cost of registration includes program tuition, networking event on Monday evening, and continental breakfast served Tuesday, Wednesday, and Thursday. Once you register for the program, you will receive a confirmation and a link to make your hotel reservations.

  • Early Bird through December 31, 2022

    • $1000
  • Registration after December 31, 2022

    • $1200

Hotel Information

Our Pathology in the Islands program is at Atlantis Paradise Island—an ocean-themed resort in the Bahamas. Atlantis offers an incredible range of activities, all against the backdrop of Paradise, where you can rest, play, and rejuvenate.

Guests can enjoy swimming, snorkeling/diving, chartered fishing, beach and pools, water park, golf, tennis, gambling, fitness center, and spa.

Note: Activities may incur an additional cost to participate. Atlantis Paradise Island’s Concierge Services can assist you to make arrangements.

Room Rate

$269.00 + $25 Resort Fee + 11.2% tax = $324.00 (Based on double occupancy)

  • Children under 12: There is no additional charge for children under 12 years of age staying with an adult.
  • Reservations are available on a first come, first served basis, and must be made by June 1, 2023.
  • Reservations must be accompanied by 2 nights room and tax deposit.

Check-In Time: 4:00 PM CT

Check-Out Time: 11:00 AM CT

Atlantis Paradise Island
One Casino Drive, Suite 41
Paradise Island, The Bahamas
1-800-386-4786

  • Please keep in mind, we only have rooms available on the evenings of June 25 - 28 and a limited number for the evening of June 29. Please notify Atlantis if you wish to extend your stay as soon as possible. Additional nights will be based on hotel availability.
  • Room upgrade: If you wish to upgrade your accommodations or extend your stay, you will need to work with Atlantis Paradise Island reservations—any additional cost is the attendee’s responsibility and subject to hotel availability.
  • Cancellations: Individual guest room reservations may be canceled without penalty up to 72-hours prior to your confirmed check-in date. If the reservation is cancelled after this time, you will forfeit your deposit.

Transportation

Important! Both US and Bahamas Immigration Laws require all travelers to have a valid passport.

Please book air fare 21 days prior to departure from city where travel begins.

When traveling to Atlantis confirm your flights into LYNDEN PINDLING INTERNATIONAL AIRPORT (formerly Nassau International Airport, airport code NAS). Most major airlines offer international service with either non-stop or connecting service into NAS.

Transfers to and from the resort are offered on the Atlantis Web site when booking your vacation.

Taxis are also readily available at NAS to transport you to Atlantis. For more information on transportation services at NAS, including rental cars, visit their website.

Within the Atlantis, there is a Complimentary shuttle service offered to facilities to get around Atlantis and Ocean Club. For more information, visit the Guest Services Desk in the lobby or call ext. 28.

Cancellation Policy

Should you need to cancel your registration for this program, please contact the CAP as soon as possible. The CAP will apply your payment to a future program or refund your registration fee, less a $100.00 processing fee, up to two weeks prior to the program; refunds after that date will be considered on a case-by-case basis.

The CAP reserves the right to cancel any CME workshop without prior notice for insufficient preregistration or any other reason. The CAP is not responsible for participant airline or hotel cancellation penalties or any other losses incurred as a result of cancellation.

CME Information

Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Category 1: The College of American Pathologists designates this live educational activity for a maximum of 16.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the American Board of Pathology’s (ABP) Continuing Certification (CC) requirements for Self-Assessment Modules (SAMs).

Save with Early Bird Pricing

Register for Pathology in the Park before January 13, 2023, to receive a reduced registration rate

Register Now Right Arrow